Introduction: Hypoglycemia is frequently encountered in the emergency department (ED) and has potential for serious morbidity. The incidence and causes of iatrogenic hypoglycemia are not known. We aim to describe how often the cause of ED hypoglycemia is iatrogenic and to identify its specific causes.

Methods: We included adult patients with a chief complaint or ED diagnosis of hypoglycemia, or an ED glucose value of ≤70 milligrams per deciliter (mg/dL) between 2009-2014. Two independent abstractors each reviewed charts of patients with an initial glucose ≤ 50 mg/dL, or initial glucose ≥ 70 mg/dL with a subsequent glucose ≤ 50 mg/dL, to determine if the hypoglycemia was caused by iatrogenesis. The data analysis was descriptive.

Results: We reviewed the charts of 591 patients meeting inclusion criteria. Of these 591 patients, 99 (17%; 95% confidence interval, 14-20%) were classified as iatrogenic. Of these 99 patients, 61 (61%) cases of hypoglycemia were caused by insulin administration and 38 (38%) were caused by unrecognized malnutrition. Of the 61 patients with iatrogenic hypoglycemia after ED insulin administration, 45 and 15 patients received insulin for hyperkalemia and uncomplicated hyperglycemia, respectively. One patient received insulin for diabetic ketoacidosis.

Conclusion: In ED patients with hypoglycemia, iatrogenic causes are relatively common. The most frequent cause was insulin administration for hyperkalemia and uncomplicated hyperglycemia. Additionally, patients at risk of hypoglycemia in the absence of insulin, including those with alcohol intoxication or poor nutritional status, should be monitored closely in the ED.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754198PMC
http://dx.doi.org/10.5811/westjem.2019.7.42996DOI Listing

Publication Analysis

Top Keywords

iatrogenic hypoglycemia
12
insulin administration
12
hypoglycemia
10
patients
9
incidence iatrogenic
8
emergency department
8
hypoglycemia iatrogenic
8
reviewed charts
8
initial glucose
8
glucose ≤
8

Similar Publications

Background: Diazoxide is the sole approved drug for congenital hyperinsulinism; however, diuretic administration and vigilant monitoring are crucial to prevent and promptly identify potentially life-threatening adverse effects. This report aims to highlight a seldom-considered rare side effect of diazoxide. We believe that this brief report is of general interest to readership and increase the physicians' awareness of the guideline importance.

View Article and Find Full Text PDF

Headache in diabetes.

J Pak Med Assoc

October 2024

Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India; Non-communicable disease unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

Diabetes can present with multiple manifestations and subjective symptoms. One of these is headache. Headache can be a clinical presentation of diabetes per se, its complications or its comorbidities.

View Article and Find Full Text PDF
Article Synopsis
  • - Quality assessment organizations use various patient safety measures to evaluate hospitals, but these assessments can create significant burdens for health systems.
  • - The Braden score is a bedside evaluation tool typically used to assess the risk of pressure injuries, and this study suggests it could be effective in predicting other adverse outcomes like mortality and infections.
  • - The research indicates that abnormal Braden scores correlate with several negative health outcomes, highlighting the potential of this low-cost tool to quickly identify high-risk patients and improve overall patient safety despite advancements in technology.
View Article and Find Full Text PDF

It is time to eliminate unnecessary iatrogenic hypoglycemia in older adults.

J Am Geriatr Soc

October 2024

Charles E. Schmidt College of Medicine, Christine E. Lynn College of Nursing, Florida Atlantic University, Boca Raton, Florida, USA.

View Article and Find Full Text PDF

Introduction: Iatrogenic hypoglycaemia is an event that should be avoided in the treatment of diabetes, but the pathophysiology thereof has been poorly examined and reported. There is no established method for preventing iatrogenic hypoglycaemia and the current approach is a reactive response following onset of the disease. In this study, we aimed to explore the existence of 'hypoglycaemia-vulnerable hours of the day' in patients with type 2 diabetes, with the ultimate goal of preventing the onset of iatrogenic hypoglycaemia by clarifying the time when severe hypoglycaemia is likely to occur.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!